Azitra Inc logo — Harnessing the microbiome to treat skin disease.

Azitra Inc

Harnessing the microbiome to treat skin disease.

Founded 2014 United States Branford, United States 12 employees Post-IPO Equity Total: $52.84M Biotechnology, Consumer Goods +1

General Information

Company Name Azitra Inc
Founded Year 2014
Location United States Branford, United States
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Consumer Goods, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Azitra Inc. To contact Azitra Inc, visit azitrainc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Azitra Inc compare?

A PDF of Azitra Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Azitra Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Azitra Inc

Azitra Inc is a biotechnology startup founded in 2014 with a focus on harnessing the power of the microbiome to treat skin disease. The company has established itself as a preclinical stage biotechnology firm, leveraging the expertise of scientists from Yale University and collaborating with leading experts in dermatology, microbiology, and genetic engineering. Azitra is dedicated to advancing its programs in atopic dermatitis and targeted orphan indications. The company's last investment of $5.00MPost-IPO Equity was received on 13 February 2024, marking a milestone in its growth trajectory. With its headquarters in the United States, Azitra is positioning itself as a promising player in the biotechnology, consumer goods, and healthcare sectors. For more information, visit www.azitrainc.com.

Business keywords: microbiome, skin disease, preclinical stage, atopic dermatitis, dermatology, microbiology, genetic engineering, Yale University, treatment, biopharmaceutical, skin microbiome, innovation, startup

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $10.00M -
23 Jul 2024
Post IPO Equity $5.00M -
13 Feb 2024
Series B $17.00M 3
Connecticut Innovations, Bios Partners +1
15 Oct 2020
Series A $14.00M 4
Connecticut Innovations, KdT Ventures +2
15 Oct 2019
Grant $719.70K 1
National Science Foundation
09 Apr 2019
Venture Round Undisclosed 1
Sahsen Ventures
01 Jan 2019
Grant $500.00K 1
U.S. Department of Defense
13 Sep 2018
Grant $225.00K 2
NIAMS, National Institutes of Health
01 Aug 2018
Convertible Note $2.15M 3
Connecticut Innovations, KdT Ventures +1
02 May 2018
Series A $2.90M 1
Bios Partners
05 Apr 2017

View All 11 Funding Rounds

Azitra Inc Alternatives & Competitors

View All Alternatives
Azitra Inc vs

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

Convertible Note
6 employees
Biopharma, Biotechnology
Azitra Inc vs
DermBiont, Inc.
DermBiont, Inc. United States

Advancing targeted topical therapeutics for dermatological indications

Series A
18 employees
Biotechnology, Health Care
Azitra Inc vs

Topical nanomedicines for treating dermatological conditions

3 employees
Biotechnology, Health Care

FAQ About Azitra Inc

Harnessing the microbiome to treat skin disease.
Azitra Inc was founded in 2014.
Azitra Inc is headquartered in Branford, United States.
Azitra Inc operates in Biotechnology, Consumer Goods and Health Care. Its work centres on microbiome, skin disease, preclinical stage and atopic dermatitis.
Azitra Inc has approximately 12 employees.
Azitra Inc has completed 11 funding rounds, raising a total of $52.84M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Azitra Inc include MatriSys Bioscience, Inc., DermBiont, Inc., Blueberry Therapeutics Ltd, SFA Therapeutics, ASLAN Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Azitra Inc and MatriSys Bioscience, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Azitra Inc, https://bouncewatch.com/company/azitra-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes